Going Down: Zeneca

Sunday 11 April 1999 00:02 BST

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

ZENECA GROUP said it completed its $40bn (pounds 24.8bn) takeover of Sweden's Astra, creating the world's biggest drugmaker, after Astra shareholders voted to approve its all-share offer. The shares fell more than 8 per cent.

The enlarged company leapfrogs Novartis and Merck & Co in size, with 1998 drug sales of $10.68bn. Rivals in the $300 billion drug industry are joining forces at a record pace to boost their pipelines of new drugs and slash costs.

The company now has to succeed in cutting 11 per cent of its workforce, integrating two different cultures and overcoming the expiration of patents on its best-selling drugs.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Stay up to date with notifications from The Independent

Thank you for registering

Going Down: Zeneca

Join our commenting forum

Thank you for registering